- Clinical Trials
- January 2024
- 90 Pages
Global
From €1417EUR$1,500USD£1,205GBP
- Report
- April 2023
- 147 Pages
Global
From €4674EUR$4,949USD£3,975GBP
- Report
- January 2024
- 200 Pages
Global
From €3919EUR$4,150USD£3,334GBP
- Report
- April 2021
Global
From €4203EUR$4,450USD£3,575GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1417EUR$1,500USD£1,205GBP
- Report
- March 2024
- 165 Pages
Global
From €2361EUR$2,500USD£2,008GBP
- Report
- February 2024
- 175 Pages
Global
From €2361EUR$2,500USD£2,008GBP
- Report
- January 2024
- 163 Pages
Global
From €2361EUR$2,500USD£2,008GBP
- Report
- February 2024
- 150 Pages
Global
From €4486EUR$4,750USD£3,815GBP
- Report
- February 2024
- 111 Pages
Global
From €4486EUR$4,750USD£3,815GBP
- Report
- April 2023
- 120 Pages
Global
From €4486EUR$4,750USD£3,815GBP
- Report
- April 2023
- 120 Pages
Global
From €4486EUR$4,750USD£3,815GBP
- Report
- April 2020
- 129 Pages
Global
From €4486EUR$4,750USD£3,815GBP
- Report
- May 2024
- 99 Pages
From €3258EUR$3,450USD£2,771GBP
- Report
- January 2025
- 82 Pages
India
From €3305EUR$3,500USD£2,811GBP
- Report
- December 2024
- 70 Pages
India
From €3305EUR$3,500USD£2,811GBP
From €3305EUR$3,500USD£2,811GBP
- Report
- October 2023
- 175 Pages
Global
From €4250EUR$4,500USD£3,615GBP
- Report
- October 2023
- 190 Pages
Global
From €4250EUR$4,500USD£3,615GBP
- Report
- October 2023
- 190 Pages
Global
From €4250EUR$4,500USD£3,615GBP

The Antibiotics market is a sector of the pharmaceutical industry that focuses on the development, production, and distribution of drugs used to treat bacterial infections. Antibiotics are used to treat a wide range of bacterial infections, from minor skin infections to life-threatening illnesses such as pneumonia and meningitis. Antibiotics are also used to prevent infections in people who are at risk of developing them, such as those undergoing surgery or chemotherapy.
The Antibiotics market is highly competitive, with many large pharmaceutical companies competing for market share. Companies in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, and Johnson & Johnson. These companies are constantly researching and developing new antibiotics to treat a variety of bacterial infections. Show Less Read more